Dr Shelley H Ray, MD | |
1419 Hamric Dr E Ste 101, Oxford, AL 36203-2174 | |
(256) 235-3660 | |
(256) 235-3663 |
Full Name | Dr Shelley H Ray |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 29 Years |
Location | 1419 Hamric Dr E Ste 101, Oxford, Alabama |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447259643 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 23813 (Alabama) | Secondary |
207N00000X | Dermatology | MD.23813 (Alabama) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Forefront Dermatology | 3779471701 | 474 |
News Archive
Labopharm Inc. today announced that it has been informed by Angelini, the manufacturer of the active pharmaceutical ingredient (API) for the Company's novel trazodone formulation, that it has received a letter from the U.S. Food and Drug Administration (FDA) stating that Angelini has appropriately addressed all deficiencies cited by the FDA following its inspection of the manufacturing facility in June and July of this year.
Researchers have found that stethoscopes carried by healthcare practitioners in an intensive care (ICU) setting are loaded with a wide range of bacteria.
Express Scripts, Inc., and WellPoint, Inc., announced today the closing of Express Scripts' acquisition of WellPoint's NextRx subsidiaries.
This week, the University of Leicester launches a new Centre for Genetic Architecture of Complex Traits to explore the building blocks of complex traits and disease.
› Verified 8 days ago
Entity Name | Advanced Dermatology & Skin Care Specialists, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801969480 PECOS PAC ID: 4385677657 Enrollment ID: O20050916000242 |
News Archive
Labopharm Inc. today announced that it has been informed by Angelini, the manufacturer of the active pharmaceutical ingredient (API) for the Company's novel trazodone formulation, that it has received a letter from the U.S. Food and Drug Administration (FDA) stating that Angelini has appropriately addressed all deficiencies cited by the FDA following its inspection of the manufacturing facility in June and July of this year.
Researchers have found that stethoscopes carried by healthcare practitioners in an intensive care (ICU) setting are loaded with a wide range of bacteria.
Express Scripts, Inc., and WellPoint, Inc., announced today the closing of Express Scripts' acquisition of WellPoint's NextRx subsidiaries.
This week, the University of Leicester launches a new Centre for Genetic Architecture of Complex Traits to explore the building blocks of complex traits and disease.
› Verified 8 days ago
Entity Name | Forefront Dermatology Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366936759 PECOS PAC ID: 3779471701 Enrollment ID: O20180911002840 |
News Archive
Labopharm Inc. today announced that it has been informed by Angelini, the manufacturer of the active pharmaceutical ingredient (API) for the Company's novel trazodone formulation, that it has received a letter from the U.S. Food and Drug Administration (FDA) stating that Angelini has appropriately addressed all deficiencies cited by the FDA following its inspection of the manufacturing facility in June and July of this year.
Researchers have found that stethoscopes carried by healthcare practitioners in an intensive care (ICU) setting are loaded with a wide range of bacteria.
Express Scripts, Inc., and WellPoint, Inc., announced today the closing of Express Scripts' acquisition of WellPoint's NextRx subsidiaries.
This week, the University of Leicester launches a new Centre for Genetic Architecture of Complex Traits to explore the building blocks of complex traits and disease.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shelley H Ray, MD 801 York St, Manitowoc, WI 54220-4630 Ph: (920) 663-9008 | Dr Shelley H Ray, MD 1419 Hamric Dr E Ste 101, Oxford, AL 36203-2174 Ph: (256) 235-3660 |
News Archive
Labopharm Inc. today announced that it has been informed by Angelini, the manufacturer of the active pharmaceutical ingredient (API) for the Company's novel trazodone formulation, that it has received a letter from the U.S. Food and Drug Administration (FDA) stating that Angelini has appropriately addressed all deficiencies cited by the FDA following its inspection of the manufacturing facility in June and July of this year.
Researchers have found that stethoscopes carried by healthcare practitioners in an intensive care (ICU) setting are loaded with a wide range of bacteria.
Express Scripts, Inc., and WellPoint, Inc., announced today the closing of Express Scripts' acquisition of WellPoint's NextRx subsidiaries.
This week, the University of Leicester launches a new Centre for Genetic Architecture of Complex Traits to explore the building blocks of complex traits and disease.
› Verified 8 days ago
Dr. Mahrukh Nisar, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1419 Hamric Dr E Ste 101, Oxford, AL 36203 Phone: 256-235-3660 |